NOTICE TO READER:
As with all of our Q&A sessions, we were not approached or requested to undertake the Q&A but rather we approach those companies that we feel the timing is right. No compensation of any kind or in any form is every offered, requested, expected, or received.
CCIM: Frank, thank you for taking the time to introduce NDEV not only to our subscribers but to all of Canada.
First of all, congratulations on a number of Q3 Highlights, name:
Key Milestones Achieved in Q3 2017:
F Revenues increased 62%, year over year
F Revenue increased for the 5th consecutive quarter
F 4th consecutive quarter of increased profitability
F Added Providers for wider access for procuring patient members
F Increased awareness through strategic direct marketing relationships
F Attained a Canadian federal charter for expansion into Canada
F Cash on hand has increased to $97,476 from $83,276 at the
end of the second quarter
F NAV increased 4% to $1,450,308.
NDEV: Thank you, I am partially proud of all our accomplishments but this industry is still in its infancy and there much more work to do and much more infrastructure to build.
CCIM: The green bold highlight titled “Attained a Canadian federal charter for expansion into Canada” will be of interest to our readers as well as to medical marijuana patients coast to coast. When do you expect this benefit package to be available in Canada?
182
Q& A
Louis Kyron: CCIM Frank Labrozzi, CEO: NDEV
NEW